Analysis and Perspectives
Apr 23, 2021
Pharma Companies Foray into the ABSSSI Market to Develop Novel Antibiotics and Tackle Antibiotic Resistance
The ABSSSI pipeline, as per DelveInsight, appears quite active with several emerging candidates in Phase III and Phase II stages of development.
Read More...
Apr 09, 2021
Limited Therapeutics Options and A Weak Pipeline: What Lies Ahead in the Cancer Anorexia Market?
Off-label therapies continue to dominate the Cancer Anorexia market, which is expected to change in the next decade.
Read More...
Apr 05, 2021
Kinase Inhibitors: Challenging the established Biologics as the new standard of care in autoimmune diseases?
Emerging therapies include Ritlecitinib, Ritlecitinib/PF-06650833/ Tofacitinib, Abrocitinib, PF-06826647, Brepocitinib (Pfizer), SHR0302 (Reinstone Biopharma)...
Read More...
Mar 05, 2021
Rare Cancer Market: A Global Crusade on what is a ‘less common cancer’?
Of all the diagnosed cancers, approximately 22% of the cases are rare cancers or 1 in 5 people diagnosed with cancer has a rare type.
Read More...
Feb 26, 2021
Gene and Cell Therapies in CNS Disorders: Miracle Cure? Opportunities Galore!
One-time high payment may discourage payers to opt for GCT, however, key players feel otherwise.
Read More...
Aug 10, 2020
Medical Marijuana: Is it a blessing in disguise or a curse for humanity?
Key companies in the market: MedReleaf, Tetra Bio-Pharma, TO Pharmaceuticals, Corbus Pharmaceuticals, Therapix Biosciences, Arena Pharmaceuticals, Canbex Therapeutics, Daisy Pharma Opioid Venture, Tilray...
Read More...
Apr 10, 2020
Future Perspectives Of CAR-T Cell Therapy Market In Acute Lymphoblastic Leukemia (ALL)
Car-T cell therapy market worth in Acute lymphoblastic leukaemia to reach USD 1,315.7 million in the 6MM by 2030.
Read More...
-Agonist.png "Toll-like Receptors Agonist")
